TrialJournal of hematology & oncology2019

Prognostic or predictive value of circulating cytokines and angiogenic factors for initial treatment of multiple myeloma in the GIMEMA MM0305 randomized controlled trial.

Ilaria Saltarella et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.